Natural Alternatives and Nanotechnology Applied to the One Health Approach: Bridging Ecology, Technology, and Medicine for Sustainable Solutions
暫譯: 自然替代方案與納米技術應用於一體健康方法：連結生態、技術與醫學以實現可持續解決方案
Heya, Michel Stéphane
相關主題
商品描述
The search for reliable, sustainable, and environmentally friendly alternatives has become a global trend due to critical limits worldwide regarding increased pharmacological resistance, pharmaceutical pollution and rising human and zoonotic diseases. Although research based on medicinal plants, algae, blood therapy, among others, has not yet reached its peak, it has shown promising results and become a reliable and sustainable hope for combating emerging human diseases.
In recent decades, innovations have included the use of nanovehicles to deliver pharmacologically active compounds, aiming to enhance their curative effect, pharmacological selectivity, and controlled release. While some studies highlight the limitations of nanovehicles/nanodrugs, most acknowledge their superiority over conventional dosing forms. Nanodrugs can overcome various physiological barriers in the human body, providing controlled drug release at the desired site, increasing therapeutic potential, and reducing toxicity. They also enhance pharmacokinetics and pharmacodynamics.
Natural Alternatives and Nanotechnology Applied to the One Health Approach explores the pharmacological potential of various natural sources to combat certain human and zoonotic diseases and the contribution of nanotechnology in dosing active compounds for select diseases.
商品描述(中文翻譯)
尋找可靠、可持續且環保的替代方案已成為全球趨勢，這是因為全球在藥物抗性增加、藥物污染以及人類和動物傳染病上面臨的重大限制。儘管基於藥用植物、藻類、血液療法等的研究尚未達到巔峰，但已顯示出有希望的結果，並成為對抗新興人類疾病的可靠和可持續的希望。
在近幾十年中，創新包括使用奈米載體來傳遞藥理活性化合物，旨在增強其治療效果、藥理選擇性和控制釋放。雖然一些研究強調奈米載體/奈米藥物的局限性，但大多數研究承認它們相較於傳統劑量形式的優越性。奈米藥物可以克服人體內的各種生理障礙，在所需部位提供控制釋放的藥物，增加治療潛力並降低毒性。它們還增強了藥物動力學和藥效學。
《自然替代方案與應用於一體健康方法的奈米技術》探討了各種自然來源的藥理潛力，以對抗某些人類和動物傳染病，以及奈米技術在特定疾病中劑量活性化合物的貢獻。
作者簡介
Dr. Michel Heya has a PhD in Sciences with an Orientation in Biotechnology from the Institute of Biotechnology of the Autonomous University of Nuevo Leon, Mexico. He works in the bioprospecting of green alternatives for the treatment of human conditions, as well as in the development of nanomedicines for the pharmacological dosage of various active ingredients. Currently a member of the National System of Researchers and Investigators (SNII), Heya is the author of several scientific articles published in indexed journals and has been a reviewer in journals such as the International Journal of Food Properties and Chemistry & Biodiversity (Web of Sciences Group: ID: 3298-2022). Additionally, Heya is a professor and researcher at the Faculty of Public Health and Nutrition and has participated in the training of scientific resources by directing Master's and Bachelor's theses.
作者簡介(中文翻譯)
米歇爾·海亞博士擁有墨西哥新萊昂自治大學生物技術研究所的生物科學博士學位，專攻生物技術。他專注於尋找綠色替代方案以治療人類疾病，並開發納米藥物以進行各種活性成分的藥理劑量。目前，他是國家研究人員系統（SNII）的成員，並且是多篇發表於索引期刊的科學文章的作者，曾擔任《國際食品性質期刊》和《化學與生物多樣性》（Web of Sciences Group: ID: 3298-2022）等期刊的審稿人。此外，海亞博士是公共衛生與營養學院的教授和研究員，並參與指導碩士和學士論文，以培養科學人才。
